A very strong COVID VACCINE performance to close out the week with fully 20 stocks registering a gain with seven down. The overall average gain was 2.8%.
iBio lead the group with a gain of over 20% with Nano Viricides continuing its strong performance of late with a gain of just under 16%. Altimmune was the third stock with a greater than double digit gain - climbing over 11% to close at $14.35.
Generex had a strong day, up close to 8% while Arcturus and Gridstone each gained over 6%.
GeoVax fell over 8% to lead the way on the downside.
No comments:
Post a Comment